Skip to main content

Zymaxid Side Effects

Generic name: gatifloxacin ophthalmic

Medically reviewed by Drugs.com. Last updated on May 18, 2024.

Note: This document contains side effect information about gatifloxacin ophthalmic. Some dosage forms listed on this page may not apply to the brand name Zymaxid.

Applies to gatifloxacin ophthalmic: ophthalmic solution.

Serious side effects of Zymaxid

Along with its needed effects, gatifloxacin ophthalmic (the active ingredient contained in Zymaxid) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking gatifloxacin ophthalmic:

More common

Less common

Rare

Incidence not known

Other side effects of Zymaxid

Some side effects of gatifloxacin ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to gatifloxacin ophthalmic: ophthalmic solution.

Ocular

Common (1% to 10%): Conjunctival irritation, increased lacrimation, keratitis, papillary conjunctivitis, chemosis, conjunctival hemorrhage, dry eye, eye discharge, worsening of conjunctivitis, eye irritation, eye pain, eyelid edema, red eye, decreased visual acuity

Postmarketing reports: Blepharitis, eye pruritus, eye swelling (including corneal and conjunctival edema), blurred vision[Ref]

Nervous system

Common (1% to 10%): Headache, dysgeusia/taste disturbance[Ref]

Hypersensitivity

Postmarketing reports: Anaphylactic reactions, hypersensitivity[Ref]

Dermatologic

Postmarketing reports: Angioedema (including pharyngeal, oral, or facial edema), pruritus (including generalized pruritus), rash, urticaria[Ref]

Gastrointestinal

Postmarketing reports: Nausea[Ref]

Respiratory

Postmarketing reports: Dyspnea[Ref]

References

1. (2003) "Product Information. Zymar (gatifloxacin ophthalmic)." Allergan Inc

2. (2015) "Product Information. Zymaxid (gatifloxacin ophthalmic)." A-S Medication Solutions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.